| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 226,859 | 202,163 | 245,064 | 192,687 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 202,163 | 245,064 | 192,687 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 371,347 | 560,614 | 382,947 | 463,063 | | Non Recurring |
-
| (40,021) | 40,021 |
-
| | Others | 4,151 | 3,753 | 3,345 | 4,512 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (181,560) | (322,183) | (181,249) | (274,888) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (156,854) | (319,737) | (183,695) | (280,860) | | Interest Expense | 9,338 | 11,731 | 11,852 | 13,015 | | Income Before Tax | (166,192) | (331,468) | (195,547) | (293,875) | | Income Tax Expense | (74,434) | (112,679) | (80,286) | (112,882) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (87,920) | (222,627) | (115,261) | (180,993) | | | Non-recurring Events | | Discontinued Operations | (5,312) | 7 | (30) | 2,148 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (93,232) | (222,620) | (115,291) | (178,845) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($93,232) | ($222,620) | ($115,291) | ($178,845) |
|
1.48% Nasdaq 
Income Statement
